Emergent Biosolutions EBS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Commercial Products | $223.7M-1.1% | $226.1M-10.6% | $252.8M-7.5% | $273.2M-16.1% | $325.7M-18.4% | |
| MCM Products | $401.9M-12.0% | $456.7M-3.7% | $474.3M-6.3% | $506M-1.0% | $511M+0.2% | |
| Total revenues by Product | ||||||
| All other revenue | $51.2M-14.8% | $60.1M-2.8% | $61.8M-14.6% | $72.4M-43.7% | $128.7M-4.6% | |
| Commercial Product sales | $223.7M-1.1% | $226.1M-10.6% | $252.8M-7.5% | $273.2M-16.1% | $325.7M-18.4% | |
| MCM Product sales | $401.9M-12.0% | $456.7M-3.7% | $474.3M-6.3% | $506M-1.0% | $511M+0.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Emergent Biosolutions break its business down?
- Emergent Biosolutions (EBS) reports total revenues by business across 2 parts — Commercial Products and MCM Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Emergent Biosolutions's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Emergent Biosolutions's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
